Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For March 30 (RIMM, THLD, IMGN, XRTX, SHPGY, DNKN, FINL)

RELATED NEWS
Trade BBRY now with 

Gainers:

Threshold Pharmaceuticals, Inc. (THLD: Quote) is rising 6 percent to $8.93 based on the news that FDA has granted orphan drug designation for TH-302, a hypoxia-targeted drug, for treating soft tissue sarcoma.

ImmunoGen, Inc.(IMGN: Quote) is gaining 13 percent to $15.50 based on the announcement of positive results in the trastuzumab emtansine (T-DM1) EMILIA Phase III trial and the announcement of initiation of Phase II evaluation of IMGN901.

Research In Motion Ltd. (RIMM: Quote) is up nearly 2 percent to $13.97. The company announced that it is simultaneously conducting a comprehensive review of strategic opportunities. The company slipped to a loss in its fourth quarter. Both earnings per share, excluding items, and revenue were below Wall Street view.

Decliners:

Xyratex Ltd. (XRTX: Quote) is falling 9 percent to $16.10. The company's first quarter profit improved from the previous year. However, revenues declined 18 percent, and were also below consensus. The company guided second quarter results in-line with market view.

Shire plc (SHPGY: Quote) is falling more than 3 percent to $97.98. The company announced that PREVENT2 trial, a phase 3 investigational study of once-daily SPD476, MMX mesalamine in patients with a history of diverticulitis, did not meet the primary endpoint in reducing the rate of recurrence of diverticulitis over a 2-year treatment period.

Dunkin' Brands Group, Inc. (DNKN: Quote) is falling 0.33 percent to $29.96. The company announced the pricing of an upsized public offering by certain of its stockholders of 26.4 million shares of its common stock at $29.50 per share.

Finish Line Inc. (FINL: Quote) is declining 7 percent to $23.50. The company's fourth quarter non-GAAP earnings per share, matched analysts' estimate. Consolidated net sales rose 18.6 percent and were above consensus. The company guided first quarter earnings per share to be down approximately 30 percent.

Register
To receive FREE breaking news email alerts for BlackBerry and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.